Screener
Estrella Immunopharma, Inc. ESLA Q2 2025 earnings
Reported August 11, 2025 · Before market open
EPS-$0.15Miss by $0.08
EPS estimate-$0.07
Next report
Dec 2, 2026 (in 2 months)EPS estimate-$0.08
Versus estimates
Diluted EPS
FAQ
- When did Estrella Immunopharma, Inc. report Q2 2025 earnings?
- Estrella Immunopharma, Inc. (ESLA) reported Q2 2025 earnings on August 11, 2025 before market open.
- What were Estrella Immunopharma, Inc.'s Q2 2025 revenue and EPS?
- Estrella Immunopharma, Inc. reported eps of $-0.15 for Q2 2025.
- Did Estrella Immunopharma, Inc. beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-0.07 by $0.08.
- How did Estrella Immunopharma, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 15.4% from $-0.13.
- Where can I find Estrella Immunopharma, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001213900-25-074567) directly on SEC EDGAR. The filing index links above go to sec.gov.
